Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001837944 | SCV001532430 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001837944 | SCV002776117 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2021-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003302746 | SCV004000636 | uncertain significance | Cardiovascular phenotype | 2023-04-30 | criteria provided, single submitter | clinical testing | The p.R532Q variant (also known as c.1595G>A), located in coding exon 12 of the APOB gene, results from a G to A substitution at nucleotide position 1595. The arginine at codon 532 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000508794 | SCV000605978 | benign | not specified | no assertion criteria provided | research |